» Articles » PMID: 10816663

Corticotropin Releasing Factor Receptors and Their Ligand Family

Overview
Specialty Science
Date 2000 May 19
PMID 10816663
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

The CRF receptors belong to the VIP/GRF/PTH family of G-protein coupled receptors whose actions are mediated through activation of adenylate cyclase. Two CRF receptors, encoded by distinct genes, CRF-R1 and CRF-R2, and that can exist in two alternatively spliced forms, have been cloned. The type-1 receptor is expressed in many areas of the rodent brain, as well as in the pituitary, gonads, and skin. In the rodent, one splice variant of the type-2 receptor, CRF-R2 alpha, is expressed mainly in the brain, whereas the other variant, CRF-R2 beta, is found not only in the CNS, but also in cardiac and skeletal muscle, epididymis, and the gastrointestinal tract. The poor correlation between the sites of expression of CRF-R2 and CRF, as well as the relatively low affinity of CRF for CRF-R2, suggested the presence of another ligand, whose existence was confirmed in our cloning of urocortin. This CRF-like peptide is found not only in brain, but also in peripheral sites, such as lymphocytes. The broad tissue distribution of CRF receptors and their ligands underscores the important role of this system in maintenance of homeostasis. Functional studies of the two receptor types reveal differences in the specificity for CRF and related ligands. On the basis of its greater affinity for urocortin, in comparison with CRF, as well as its brain distribution, CRF-R2 may be the cognate receptor for urocortin. Mutagenesis studies of CRF receptors directed toward understanding the basis for their specificity, provide insight into the structural determinants for hormone-receptor recognition and signal transduction.

Citing Articles

Interaction between corticotropin-releasing factor, orexin, and dynorphin in the infralimbic cortex may mediate exacerbated alcohol-seeking behavior.

Flores-Ramirez F, Illenberger J, Martin-Fardon R Neurobiol Stress. 2024; 33:100695.

PMID: 39640001 PMC: 11617300. DOI: 10.1016/j.ynstr.2024.100695.


Role of CRH in colitis and colitis-associated cancer: a combinative result of central and peripheral effects?.

Zhu C, Li S Front Endocrinol (Lausanne). 2024; 15:1363748.

PMID: 38616821 PMC: 11010637. DOI: 10.3389/fendo.2024.1363748.


Inflammation and Impaired Gut Physiology in Post-operative Ileus: Mechanisms and the Treatment Options.

Hussain Z, Park H J Neurogastroenterol Motil. 2022; 28(4):517-530.

PMID: 36250359 PMC: 9577567. DOI: 10.5056/jnm22100.


Effects of intracerebroventricular injection of corticotrophin releasing factor on the gene expression of ghrelin and corticotrophin releasing factor receptors in broiler chickens.

Cai Y, Song Z Anim Biosci. 2022; 35(12):1904-1910.

PMID: 35760403 PMC: 9659449. DOI: 10.5713/ab.22.0046.


Corticotropin Releasing Factor Mediates K3.1 Inhibition, Hyperexcitability, and Seizures in Acquired Epilepsy.

Tiwari M, Mohan S, Biala Y, Shor O, Benninger F, Yaari Y J Neurosci. 2022; 42(30):5843-5859.

PMID: 35732494 PMC: 9337610. DOI: 10.1523/JNEUROSCI.2475-21.2022.